(Q35128241)

6 August 2017

1 reference

title

HLA-identical stem cell transplantation: is there an optimal CD34 cell dose? (English)

1 reference

6 August 2017

S. Heimfeld

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12748658

2 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://www.nature.com/articles/1704019

1 reference

DOI

10.1038/SJ.BMT.1704019

https://api.crossref.org/works/10.1038/SJ.BMT.1704019

https://www.nature.com/articles/1704019.pdf

2 January 2024

file format

Portable Document Format

1 reference

DOI

10.1038/SJ.BMT.1704019

https://api.crossref.org/works/10.1038/SJ.BMT.1704019

Bone Marrow Transplantation

2 January 2024

published in

1 reference

6 August 2017

volume

31

1 reference

6 August 2017

issue

10

1 reference

6 August 2017

page(s)

839-845

1 reference

Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Bone marrow transplantation for sickle cell disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Historical markers in the development of allogeneic hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Genomics of unrelated-donor hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Trends in transplantation of hematopoietic stem cells from unrelated donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Bone marrow transplantation for nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Improvement in rejection, engraftment rate and survival without increase in graft-versus-host disease by high marrow cell dose in patients transplanted for aplastic anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Allogeneic blood stem cell and bone marrow transplantation for acute myelogenous leukemia and myelodysplasia: influence of stem cell source on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Current status of umbilical cord blood hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

A European reference protocol for quality assessment and clinical validation of autologous haematopoietic blood progenitor and stem cell grafts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Influence of CD34+ marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

Bone marrow transplantation of chronic myelogenous leukemia in chronic phase: evaluation of risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Nordic flow cytometry standards for CD34+ cell enumeration in blood and leukapheresis products: report from the second Nordic Workshop. Nordic Stem Cell Laboratory Group (NSCL-G)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

The influence of flow cytometric gating strategy on the standardization of CD34+ cell quantitation: an Australian multicenter study. Australasian BMT Scientists Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

CD41+ and CD42+ hematopoietic progenitor cells may predict platelet engraftment after allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704019

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704019

1 reference

6 August 2017

1 reference